Wugen to Participate in Upcoming June Investor Conferences
businesswire.com
news
2022-06-01 00:00:00

June 01, 2022 08:00 AM Eastern Daylight Time ST. LOUIS & SAN DIEGO--(BUSINESS WIRE)--Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate in two upcoming investor conferences in June:




Jefferies Healthcare Conference
Format: Presentation
Presentation Date/Time: Wednesday, June 8, 2022 at 4:30 p.m. ET
Location: New York City



2022 Truist Securities symposia-cel
Format: Panel titled 'Novel Engineered NK Cell Therapies: Pursuit of The Right Phenotype'
Presentation Date/Time: Tuesday, June 28, 2022 at 11:00 a.
